bf/NASDAQ:CDTX_icon.jpeg

NASDAQ:CDTX

Cidara Therapeutics, Inc.

  • Stock

USD

Last Close

12.95

30/08 20:00

Market Cap

51.64M

Beta: 1.34

Volume Today

40.58K

Avg: 3.19M

PE Ratio

−1.95

PFCF: −2.35

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
20.91M
-
12.07M
42.30%
49.57M
310.81%
64.29M
29.69%
63.91M
0.60%
cost of revenue
46.40M
-
68.02M
46.59%
189K
99.72%
143K
24.34%
1.52M
965.03%
gross profit
-25.49M
-
-55.95M
119.53%
49.38M
188.26%
64.14M
29.89%
62.38M
2.75%
selling and marketing expenses
general and administrative expenses
272K
-
3.31M
1,115.44%
8.84M
167.33%
12.74M
44.12%
12.90M
1.26%
14.14M
9.65%
16.24M
14.81%
15.90M
2.09%
18.74M
17.87%
18.49M
1.36%
18.33M
0.83%
selling general and administrative expenses
272K
-
3.31M
1,115.44%
8.84M
167.33%
12.74M
44.12%
12.90M
1.26%
14.14M
9.65%
16.24M
14.81%
15.90M
2.09%
18.74M
17.87%
18.49M
1.36%
18.33M
0.83%
research and development expenses
810K
-
6.71M
728.40%
23.48M
249.85%
35.70M
52.07%
42.82M
19.96%
49.14M
14.76%
46.40M
5.58%
68.02M
46.59%
73.09M
7.45%
75.52M
3.33%
68.53M
9.25%
other expenses
-167K
-
-183K
9.58%
-211K
-
cost and expenses
1.08M
-
10.02M
825.69%
32.31M
222.61%
48.44M
49.90%
55.72M
15.04%
63.28M
13.57%
62.64M
1.02%
83.92M
33.97%
91.83M
9.43%
94.01M
2.37%
88.39M
5.98%
operating expenses
1.08M
-
10.02M
825.69%
32.31M
222.61%
48.44M
49.90%
55.72M
15.04%
63.28M
13.57%
62.64M
1.02%
83.92M
33.97%
91.83M
9.43%
94.01M
2.37%
86.86M
7.60%
interest expense
120K
-
271K
125.83%
-7K
102.58%
629K
9,085.71%
221K
64.86%
-262K
218.55%
212K
180.92%
191K
9.91%
ebitda
-1.08M
-
-8.23M
660.63%
-32.31M
292.62%
-48.44M
49.90%
-55.72M
15.04%
-67.14M
20.49%
-42.13M
37.24%
-71.62M
69.98%
-42.26M
41.00%
-29.72M
29.67%
-24.37M
17.99%
operating income
-1.08M
-
-11.62M
974.21%
-32.31M
178.01%
-48.44M
49.90%
-55.72M
15.04%
-63.28M
13.57%
-41.72M
34.07%
-71.85M
72.20%
-42.26M
41.19%
-29.72M
29.67%
-24.48M
17.62%
depreciation and amortization
179K
-
461K
157.54%
732K
58.79%
667K
8.88%
523K
21.59%
-411K
178.59%
229K
155.72%
-1.23M
637.12%
1.23M
199.59%
112K
90.86%
total other income expenses net
-167K
-
-1.79M
971.86%
120K
106.70%
271K
125.83%
-7K
102.58%
3.64M
52,100%
632K
82.64%
-262K
141.46%
-212K
19.08%
191K
190.09%
2.00M
944.50%
income before tax
-1.34M
-
-11.89M
784.97%
-32.19M
170.67%
-48.16M
49.61%
-55.73M
15.70%
-59.02M
5.90%
-41.09M
30.37%
-72.11M
75.49%
-42.47M
41.11%
-29.53M
30.47%
-22.49M
23.84%
income tax expense
1.70M
-
-461K
127.20%
-732K
58.79%
-667K
8.88%
4.27M
740.03%
-1.01M
123.59%
262K
126.02%
1.44M
450.38%
272K
81.14%
443K
62.87%
net income
-1.34M
-
-11.89M
784.97%
-32.19M
170.67%
-48.16M
49.61%
-55.73M
15.70%
-59.02M
5.90%
-40.09M
32.08%
-72.37M
80.55%
-43.91M
39.33%
-29.80M
32.13%
-22.93M
23.05%
weighted average shs out
3.07M
-
12.69M
314.12%
9.92M
21.85%
14.49M
46.05%
17.50M
20.79%
25.14M
43.67%
29.09M
15.71%
41.56M
42.84%
52.45M
26.22%
69.86M
33.18%
87.43M
25.15%
weighted average shs out dil
3.07M
-
12.69M
314.12%
9.92M
21.85%
14.49M
46.05%
17.50M
20.79%
25.87M
47.82%
29.09M
12.46%
41.56M
42.84%
52.45M
26.22%
69.86M
33.18%
87.43M
25.15%
eps
-0.44
-
-0.94
113.64%
-3.25
245.74%
-3.32
2.15%
-3.18
4.22%
-2.35
26.10%
-1.38
41.28%
-1.74
26.09%
-0.84
51.72%
-0.43
48.81%
-0.26
39.53%
epsdiluted
-0.44
-
-0.94
113.64%
-3.25
245.74%
-3.32
2.15%
-3.18
4.22%
-2.28
28.30%
-1.38
39.47%
-1.74
26.09%
-0.84
51.72%
-0.43
48.81%
-0.26
39.53%

All numbers in USD (except ratios and percentages)